Connect with us

News

AstraZeneca vaccine

Published

on

Spread Articles to Your Friends

March 2021: The ban on the use of the AstraZeneca vaccine, developed jointly by Oxford University with Thailand and a few European countries, the European Medicines Authority has said that the vaccine does not pose a risk of blood clots or blood clots. The move comes amid claims that the vaccine causes blood clots to form after use, but no scientific evidence has been found. According to the European Drug Administration (EMA), the rate of blood clotting among vaccinators is not higher than the general population. AstraZeneca says, it has fully tested the vaccine and declared it safe.


But on the other hand, according to the news agency Reuters, the Canadian Ministry of Health has also declared this vaccine safe. “There is no evidence that such incidents were caused by the use of vaccines. So far, the Canadian Department of Health has not received any reports of adverse effects from the vaccine. In Europe, Iceland, Norway and Denmark have stopped vaccinating AstraZeneca, while specific shipments of the vaccine have been blocked in Italy and Austria. At the same time, Romania has stopped using the consignment of AstraZeneca from Italy, while Estonia, Latvia, Lithuania and Luxembourg have suspended the supply of vaccine from Australia.

Continue Reading
Advertisement
Shares